In partnership with the Prostate Cancer Foundation (PCF), Johns Hopkins Medical Center and the Cedars-Sinai Medical Center, Grafik is developing a patient portal to support the National Proactive Surveillance Network’s (NPSN) long-term study of the efficacy of nonintervention for certain types of prostate cancers and patients.
Participants in the NPSN program must visit their doctor for initial consultation and for ongoing monitoring if they are eligible and accepted into the program. The portal will allow prospective patients to learn more about the program, and allow in-program patients to fill out various intake forms and surveys, manage their medical data, and ultimately, communicate and collaborate with doctors and other patients.
In addition to Johns Hopkins and Cedars-Sinai, additional institutions will join the NPSN after the portal’s launch in early 2011. By growing the study population, consolidating the study data, and exposing that data to the research community, the program and the web portal will help shed new light on disease progression and will ultimately provide better screening and evaluation tools that will prevent the overtreatment of prostate cancer.
PCF experts calculate that an estimated $3 billion in annual treatment costs might have been saved between 1986–2005 if the ability to distinguish between lethal and nonlethal cases of prostate cancer were available to healthcare professionals.
“Part of Grafik’s mission, as a company, is to collaborate with partners who do important work,” said Grafik Principal and Managing Director, Lance Wain. “We are thrilled to be part of this project and look forward to the contributions this tool will make towards science and disease management.”
For more information call Teddi Alyce Segal at Grafik 703-299-4507.
